ZNF169 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.148200E-01
Normal-vs-Stage2
4.745200E-01
Normal-vs-Stage3
2.808200E-01
Normal-vs-Stage4
3.943000E-01
Stage1-vs-Stage2
7.589400E-01
Stage1-vs-Stage3
6.415800E-03
Stage1-vs-Stage4
8.697200E-01
Stage2-vs-Stage3
2.56390000341611E-08
Stage2-vs-Stage4
9.202400E-01
Stage3-vs-Stage4
1.222180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.649400E-01
Normal-vs-AfricanAmerican
3.504400E-01
Normal-vs-Asian
4.608400E-01
Caucasian-vs-AfricanAmerican
2.377800E-01
Caucasian-vs-Asian
9.126800E-01
AfricanAmerican-vs-Asian
2.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.754000E-01
Normal-vs-Female
4.392600E-01
Male-vs-Female
3.669800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.863000E-01
Normal-vs-Age(41-60Yrs)
4.506600E-01
Normal-vs-Age(61-80Yrs)
4.612200E-01
Normal-vs-Age(81-100Yrs)
1.873400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.896200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.941600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.372800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.930800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.609800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.380600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.535200E-01
Normal-vs-Daily Drinker
4.236400E-01
Normal-vs-Weekly Drinker
3.277600E-01
Normal-vs-Occasional Drinker
3.971800E-01
Normal-vs-Social Drinker
5.669000E-01
Non Drinker-vs-Daily Drinker
6.549200E-01
Non Drinker-vs-Weekly Drinker
6.593800E-01
Non Drinker-vs-Occasional Drinker
3.801400E-01
Non Drinker-vs-Social Drinker
2.242800E-01
Daily Drinker-vs-Weekly Drinker
5.080000E-01
Daily Drinker-vs-Occasional Drinker
6.983600E-01
Daily Drinker-vs-Social Drinker
1.382370E-01
Weekly Drinker-vs-Occasional Drinker
3.753800E-01
Weekly Drinker-vs-Social Drinker
7.800200E-01
Occasional Drinker-vs-Social Drinker
4.861800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.031000E-01
Normal-vs-Grade 2
1.847570E-02
Normal-vs-Grade 3
1.057370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.478400E-01
Grade 1-vs-Grade 3
2.394800E-01
Grade 1-vs-Grade 4
2.031000E-01
Grade 2-vs-Grade 3
4.202400E-01
Grade 2-vs-Grade 4
1.847570E-02
Grade 3-vs-Grade 4
1.057370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.522800E-01
Normal-vs-NonDiabetic
4.556400E-01
Diabetic-vs-NonDiabetic
9.188200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.567800E-01
Normal-vs-NoPancreatitis
4.460600E-01
Pancreatitis-vs-NoPancreatitis
2.403000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.798600E-01
Normal-vs-N1
4.507200E-01
N0-vs-N1
5.482000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.782000E-01
Normal-vs-TP53-NonMutant
5.375600E-01
TP53-Mutant-vs-TP53-NonMutant
3.571800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
